Archives
-
Capecitabine: A Rigorous Assay-Design Framework
2026-09-22
Capecitabine is examined here as a context-sensitive fluoropyrimidine prodrug rather than a simple viability reagent. Learn how matched gastric cancer assembloids, thymidine phosphorylase biology, and orthogonal readouts can improve preclinical oncology research.
-
MK-571 (L-660,711) Research Workflows
2026-09-21
MK-571 (L-660,711) supports two distinct experimental strategies: selective cysLT1 receptor blockade in airway inflammation models and MRP1-focused transporter studies in immune cells. This practical guide connects assay design, formulation, controls, reference-study insights, and troubleshooting for more interpretable leukotriene and drug-response experiments.
-
Trypsin Workflow Guide for Cell and Protein Assays
2026-09-21
Turn Trypsin into a controlled tool for cell dissociation, protein digestion, and mechanism-focused assays rather than a one-size-fits-all reagent. This guide connects practical handling of BA5744 with the SMAD3–miRNA-140–ADAMTS-5 osteoarthritis model and carefully bounded applications in wound healing, inflammation, and viral fusion research.
-
7-dehydro Cholesterol: A Translation Framework
2026-09-20
7-dehydro Cholesterol is more than a sterol intermediate: it is a decision point linking cholesterol biosynthesis research, UVB photobiology, and disease-model biology. This article explains how to design assays that distinguish chemical substrate effects from DHCR7 genetic perturbation, using new grass carp antiviral evidence as a translational case study.
-
SVA–DDX23 Apoptotic Antiviral Mechanisms
2026-09-19
The reference study identifies a two-way interaction between Senecavirus A (SVA) and the host RNA helicase DDX23: DDX23 restricts viral replication through caspase-dependent degradation of SVA-3A, while SVA-2B promotes DDX23 loss through a separate apoptotic pathway. Reverse-genetics validation of critical amino acids strengthens the mechanistic model and suggests targets for antiviral and vaccine research.
-
Adefovir Workflows for HBV Research
2026-09-18
Adefovir (GS-0393) supports two complementary research applications: mechanistic HBV polymerase assays and OAT1-mediated renal transport studies. This workflow combines evidence-linked concentration ranges with practical formulation, assay design, and troubleshooting guidance for reproducible hepatitis B virus research.
-
Amphotericin B: Mechanism and Research Workflow
2026-09-18
Amphotericin B is an amphipathic polyene antifungal antibiotic that targets fungal membrane ergosterol and disrupts ion homeostasis. This article summarizes its molecular rationale, research benchmarks, experimental handling, immune-signaling boundaries, and relevance to fungal infection research.
-
Tacalcitol monohydrate: Research Workflows
2026-09-17
Tacalcitol monohydrate supports two practical research tracks: quantitative NGF induction in keratinocytes and VDR-linked combination studies in colorectal cancer models. This guide translates published assay conditions into reproducible dosing, sampling, troubleshooting, and interpretation strategies.
-
Bacitracin B1670: Practical Research Guide
2026-09-17
Bacitracin B1670 is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis disruption. This guide covers preparation, vehicle matching, assay controls, and QC boundaries; the product is for scientific research only and not for diagnostic, therapeutic, or medical use.
-
Protease and Phosphatase Inhibitor Cocktail Workflows
2026-09-16
Protect total protein abundance and phosphorylation states during cell, tissue, microbial, and plant sample lysis with an EDTA-free 100X formulation. This guide connects practical extraction decisions to macrophage HMGB1 signaling research, with starting conditions and troubleshooting for immunoblotting, immunoprecipitation, proteomics, and enzyme-sensitive assays.
-
JAK Inhibitors and Endothelial Cardiovascular Effects
2026-09-16
A 2025 comparative study shows that approved JAK inhibitors uniformly reduced inflammatory IL-6 release in cytokine-stimulated endothelial cells, but differed substantially in their effects on adhesion molecules, coagulation-related genes, and endothelial survival. The findings caution against treating cytokine suppression alone as evidence of cardiovascular protection and support inhibitor-specific vascular profiling.
-
Norovirus Co-opts NINJ1 for Selective Protein Secretion
2026-09-15
Song and colleagues show that murine norovirus exploits the membrane-rupture factor NINJ1 to release NS1 while also activating caspase-3-dependent processing of the NS1/2 precursor. The study links viral protein secretion to regulated cell death machinery and identifies a mechanism with implications for host–virus interactions, intestinal infection models, and interpretation of caspase perturbation experiments.
-
NHE1 Drives Octanal/Olfr2 Atherosclerosis
2026-09-15
The reference study identifies macrophage sodium-hydrogen exchanger 1 (NHE1) as a downstream effector of octanal/Olfr2 signaling in atherosclerosis. Using ApoE−/− mice, RAW264.7 macrophages, pharmacological inhibition, RNA interference, and calcium chelation, the authors connect NHE1 activity with calcium-dependent ROS production, inflammatory responses, foam cell formation, and NLRP3 inflammasome activation.
-
ABT-263 and Senescence-Linked Apoptosis
2026-09-14
ABT-263 (Navitoclax) is a powerful probe for testing how Bcl-2-family dependence changes in senescent and cancer cells. This article connects circadian-state biology, mitochondrial priming, and apoptosis assay design while distinguishing established evidence from testable hypotheses.
-
Pseudo-UTP Workflow for More Translatable mRNA
2026-09-14
Build reproducible in vitro-transcribed RNA with Pseudo-UTP while preserving matched UTP controls, rigorous product characterization, and translation-focused quality checks. This workflow connects pseudouridine-based RNA stability enhancement to mRNA vaccine development, gene therapy RNA modification, and practical assay troubleshooting.